Medartis Aims for Leadership Position in Extremities

Medartis reported 2H21 orthopedic sales of CHF 86.3 million (USD $97.5 million), +22.2% vs. 2H20. For the full year, the company generated CHF 159.9 million (USD $180.7 million) in orthopedic sales, +25.3% vs. the year prior.

The company turned in strong performances across the board, growing more than +20% in each of its product categories...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us